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Potentially relevant to the recent appearance of COVID-19 in China is the fact that there is a belt 
of selenium deficiency running from northeast to southwest in the country and, indeed, China has 
populations that have both the lowest and the highest selenium status in the world (1). A set of 
interesting studies published by the Beck laboratory in the 1990s showed that host selenium 
deficiency increased the virulence of RNA viruses such as coxsackievirus B3 and influenza A 
(2, 3). Passage through a selenium-deficient animal that was unable to produce sufficient 
antioxidant selenoproteins for its own protection resulted in the virus mutating to a virulent form 
that caused more severe pathology (2, 3). Those findings shed light on a human selenium-
deficiency disease, a cardiomyopathy known as Keshan disease, named after the area in 
northeast China where it was endemic. The disease showed a seasonal variation, suggesting a 
viral cofactor that was later identified as coxsackievirus B3 (2). When the population was 
supplemented with selenium, the incidence of Keshan disease decreased dramatically (1, 2). 
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Significant clinical benefits of selenium supplementation have also been demonstrated in other 
viral infections, as reviewed previously (4, 5), including HIV-1 [where a negative correlation 
between selenium status and mortality has been established (1, 6)]; in liver cancer linked to 
hepatitis B; and in patients with “epidemic hemorrhagic fever” that was successfully treated with 
oral sodium selenite, giving an overall 80% reduction in mortality (4, 7). As such, selenium 
appears relevant to a number of evolutionarily distinct viruses, via potential immunomodulatory 
effects that are fully consistent with the many essential roles of selenium in the immune system 
(2) and its ability (especially in deficiency) to influence viral mutation and evolution (3). These 
and other studies prompted us to hypothesize that selenium status was associated with COVID-
19 disease outcome in China. 
 
In this population-based, retrospective analysis, we collected real-time data from the Baidu 
website, a nongovernmental website that provides daily updates of the reports of the health 
commissions of each province, municipality, or city on numbers of COVID-19 confirmed cases, 
numbers cured, and numbers who died (8). [According to the National Health Commission of 
China, cured patients are those in whom temperature has returned to normal for >3 d, respiratory 
symptoms are significantly improved, lung imaging shows significant reduction of inflammation, 
and there is a negative nucleic acid test of respiratory pathogen on 2 consecutive occasions with 
a sampling interval of at least 1 d (9).] Cure rate and death rate were defined as percentage of 
patients cured or who died, respectively, from infection with SARS-CoV-2. We tracked the 
course of the outbreak from 14 February and chose data from 18 February as a “snapshot” of the 
progress of the outbreak to that date. We included provinces or municipalities with >200 cases 
and cities with >40 cases (Supplemental Table 1). 
 
The largest data sets available on selenium status in China are on hair selenium concentration 
(Supplemental Table 2), which, in a previous study, was found to be highly correlated with 
selenium intake in different Chinese districts (R2  = 0.74) (10). Data on hair selenium are 
generally more available for cities. Seventeen cities outside Hubei Province included in the study 
had documented hair selenium data (Supplemental Table 2). 
 
We compared cure rate and death rate using the Stata prtest to compare 2 proportions (StataCorp 
2019 Stata Statistical Software: Release 16). The prtest of the difference of 2 proportions uses an 
asymptotically normally distributed test statistic derived from the proportions and the SE of the 
difference. Associations between cure rates and mean regional or city hair selenium 
concentration were analyzed by fitting weighted linear regression models, weighted by the 
number of cases. P values (2-sided tests) from the F test of overall significance are presented. 
 
The cure rate inside Hubei Province, of which Wuhan is the capital, was significantly lower than 
that in all other provinces combined (designated outside-Hubei): 13.2% compared with 40.6%, 
respectively (P < 0.0001; Supplemental Table 1). Correspondingly, the death rate inside Hubei 
Province was significantly higher than the death rate in provinces outside-Hubei: 3.0% compared 
with 0.6%, respectively (P < 0.0001; Supplemental Table 1). These analyses show that the 
outcome data for Hubei and outside-Hubei are statistically distinct, necessitating the separate 
treatment of Hubei (where mortality was much higher) and outside-Hubei in our subsequent 
analyses. 
 
On inspection of the Hubei data, it is notable that the cure rate in Enshi city, at 36.4%, was much 
higher than that of other Hubei cities, where the overall cure rate was 13.1% (Supplemental 
Table 1); indeed, the Enshi cure rate was significantly different from that in the rest of Hubei 
(P < 0.0001). Enshi is renowned for its high selenium intake and status [mean ± SD: hair 
selenium: 3.13 ± 1.91 mg/kg for females and 2.21 ± 1.14 mg/kg for males (11)]—compare 
typical levels in Hubei of 0.55 mg/kg (10)—so much so that selenium toxicity was observed 
there in the 1960s (11, 12). Selenium intake in Enshi was reported as 550 µg/d in 2013 (11). 
 
Similar inspection of data from provinces outside Hubei shows that Heilongjiang Province in 
northeast China, a notoriously low-selenium region in which Keshan is located, had a much 
higher death rate, at 2.4%, than that of other provinces (0.5%; P < 0.0001). The selenium intake 
was recorded as only 16 µg/d in a 2018 publication (13), while hair selenium in the Songnen 
Plain of Heilongjiang was measured as only 0.26 mg/kg (Supplemental Table 2) (10, 13). 
 
Finally, we found a significant association between cure rate and background selenium status in 
cities outside Hubei (R2 = 0.72, F test P < 0.0001; Figure 1, Supplemental Table 2). No 
correlation analysis was done for cities inside Hubei because selenium status was only available 
for 2 cities. 
 
 
FIGURE 1. Correlation between COVID-19 cure rate in 17 cities outside Hubei, China, on 18 
February, 2020 and city population selenium status (hair selenium concentration) analyzed using 
weighted linear regression (mean ± SD = 35.5 ± 11.1, R2 = 0.72, F test P < 0.0001). Each data 
point represents the cure rate, calculated as the number of cured patients divided by the number 
of confirmed cases, expressed as a percentage. The size of the marker is proportional to the 
number of cases. 
 
Our results show an association between the reported cure rates for COVID-19 and selenium 
status. These data are consistent with the evidence of the antiviral effects of selenium from 
previous studies (2, 5–7, 14). Indeed, multiple cellular and viral mechanisms involving selenium 
and selenoproteins could influence viral pathogenicity, including virally encoded selenium-
dependent glutathione peroxidases [reviewed in (14, 15)]. Such viral mechanisms could 
contribute to the well-documented oxidative stress associated with many RNA virus infections 
(2, 5, 6, 14, 15); increased viral replication (hence increased mutation rate); and observed higher 
pathogenicity or mortality under selenium deficiency, as reported here for SARS-CoV-2. 
 
As with most ecological studies, our study has several important limitations. The association 
between hair selenium and COVID-19 cure rate that we note is based on city population 
selenium status data, mostly dating from 2011, although some data are considerably older. 
Furthermore, we were unable to collect city- or patient-level data for the following likely 
confounders: age and comorbidities such as cardiovascular disease, diabetes, chronic respiratory 
disease, hypertension, and cancer (16). We also lack information on variation in medical 
facilities and therapy protocols (including the use of traditional Chinese medicine or anti-viral 
therapies). Clearly, we were not able to adjust for these possible confounders in the analysis. 
 
We are fully aware, therefore, that the association shown is far from being robust to criticisms of 
confounding. At best, it points towards the need for further research, particularly when viewed in 
the context of associations between selenium status and disease outcome found with other 
viruses (3, 5–7). In due course, more individual-level data will emerge, and the association 
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Supplementary Table 1. COVID-19 case and mortality data on 18th February 2020  
sorted by geographic regions, Inside and Outside Hubei (1, 2) 
Place Patients Cured Died Cure Rate (%) Death Rate (%) 
Inside Hubei Province: City data 
Wuhan city 42752    
4253 
 1381 9.9  3.2  
Xiaogan city 3320 523 75 15.8  2.3  
Huanggang city 2828 941 84 33.3  3.0  
Jingzhou city 1537 339 38 22.1  2.5  
Ezhou city 1339 265 36 19.8  2.7  
Suizhou city 1278 198 25 15.5  2.0  
Xiangyang city 1163 182 21 15.6  1.8  
Huangshi city 985 254 20 25.8  2.0  
Yichang city 904 186 24 20.6  2.7  
Jingmen city 900 143 33 15.9  3.7  
Xianning city 868 205 10 23.6  1.2  
Shiyan city 626 144 2 23.0  0.3  
Xiantao city 544 121 19 22.2  3.5  
Tianmen city 500 55 11 11.0  2.2  
Qianjiang city 185 27 6 14.6  3.2  
Enshi city1 250 91 4 36.4  1.6  
Hubei province, total 59979 7927 1789 13.2 3.0 
Hubei province, total excluding Enshi 59729 7836 1785 13.1 3.0 
Arithmetic mean (SD)    20.3 (7.3) 2.4 (0.9) 
Outside Hubei: Provinces and Municipalities 
Guangdong province 1328 563 4 42.4 0.3 
Henan province 1257 525 19 41.8 1.5 
Zhejiang province 1172 536 0 45.7  0.0  
Hunan province 1007 527 4 52.3 0.4 
Anhui province 982 361 6 36.8 0.6 
Jiangxi province 933 310 1 33.2  0.1  
Jiangsu province 629 284 0 45.2 0.0 
Chongqing municipality 553 236 5 42.7  0.9  
Shandong province 543 212 3 39.0 0.6 
Sichuan province 508 168 3 33.1 0.6 
Beijing municipality 387 130 4 33.6 1.0 
Shanghai municipality 333 177 1 53.2 0.3 
Fujian province 292 93 0 31.8 0.0 
Shaanxi province 240 91 0 37.9 0.0 
Hebei province 302 137 4 45.4 1.3 
Guangxi province 242 74 2 30.6 0.8 
Heilongjiang province2 464 108 11 23.3 2.4 
Regions outside Hubei, total 11172 4532 67 40.6 0.6 
Outside Hubei, excluding Heilongjiang 10708 4424 56 41.3 0.5 
Arithmetic mean (SD)    39.3 (7.9) 0.64 (0.65) 
1Enshi city (high selenium region) and 2Heilongjiang Province (low selenium region) are selected for 
discussion in paragraphs 4 and 5 of the Results section.  
Supplementary Table 2. Data used in correlation analysis: COVID-19 cure rate data on 18th 
February 2020 for Cities Outside Hubei, with documented selenium status (hair selenium 
concentration) 
 














Guangzhou of Guangdong 339 142 41.89  0.50±0.12 (72) 3,4 
Xinyang of Henan 266 84 31.58  0.34±0.12 (100) 5 
Zhengzhou of Henan 154 76 49.35  0.59±0.10 (245) 4,5 
Hangzhou [Chun'an] of Zhejiang 168 94 55.95  1.00±0.13 (50) 3 
Suzhou of Jiangsu 87 31 35.63  0.36[0.32,0.39]2 (285) 3,4 
Wuxi of Jiangsu 55 21 38.18  0.343 (53) 3,4 
Chengdu of Sichuan 140 56 40.00  0.43±0.24 (34) 4 
Ganzi of Sichuan 62 8 12.90  0.09±0.03 (281) 6 
Harbin of Heilongjiang 190 47 24.74  0.26±0.02 (135) 3,4,7 
Suihua of Heilongjiang 46 16 34.78  0.26±0.00 (54) 3,4 
Qiqihar of Heilongjiang 43 10 23.26  0.26±0.00 (54) 3,4 
Beijing - Municipality 387 130 33.59  0.57±0.02 (331) 3,4 
Shanghai - Municipality 333 177 53.15  0.64±0.10 (396) 4 
Tangshan of Hebei 51 12 23.53  0.38±0.13 (37) 4 
Fuzhou of Fujian 71 28 39.44  0.40±0.37 (42) 4 
Nanning of Guangxi 54 18 33.33  0.39±0.14 (57) 4 
Xi'an of Shaanxi 117 37 31.62  0.29±0.12 (48) 4 
1Where values of hair selenium concentration were taken from more than one study, they have been 
weighted by numbers of samples per study; 20.32, females, 0.39 males (mg/kg); 3No SD given in the original 
reference; n=number of hair samples 
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